Most Read News

Godawari Power and Ispat Ltd shares has witnessed a total of 42% in the last one year, and 12% since the beginning of the year.

EBITDA saw a 12.4% increase, standing at ₹129.5 Crore for Q2 FY25, up from ₹115.2 Crore in the previous fiscal period.

Piramal Pharma Solutions (PPS) is set to invest $80 million in expanding its sterile injectables facility in Lexington, Kentucky, USA, projected for completion by FY27.

Revenue in Q1 FY25 had also dropped by 5.10% to ₹699.14 Crore, compared to ₹736.72 Crore in the same quarter last year.

Gensol Engineering stocks has witnessed a 9.52% dip in the last one year, and 7.5% dip since the beginning of the year.

Revenue rose to ₹8,522 Crore for the July-September quarter, with ₹6,403 Crore from zinc, lead, and other segments and ₹1,550 Crore from the silver division.

Capacity utilization for Q2 FY25 was 64% for cement production and 67% for clinker, influenced by operational disruptions at the Muddapur facility.

Distribution record date is set for October 30, 2024, with payment expected by November 9, 2024.

BPCL’s EBITDA was reported at ₹4,547 crore, reflecting a 19.5% decrease from the previous quarter. The EBITDA margin stood at 4.4%.

Gross NPA slightly increased by 2 basis points to 1.92%, while net NPA improved by 11 basis points to 0.48%.